Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Antibiotic Selection00:57

Antibiotic Selection

Overview
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Modelling the role of the microbiome in antimicrobial resistance across scales.

Nature microbiology·2026
Same author

Differential impact of the pandemic first wave on chronic respiratory diseases in France.

Respiratory medicine and research·2026
Same author

Modelling impacts of paediatric amoxicillin shortage management on pneumococcal resistance and invasive disease in Europe.

Nature communications·2026
Same author

Effects of the COVID-19 pandemic on antibiotic use and resistance in French hospitals, 2019-22: a retrospective ecological analysis of national surveillance data.

The Lancet. Digital health·2026
Same author

Replacing car-dedicated space with green spaces: an assessment of the mortality benefits in Paris.

Environmental research·2026
Same author

Mobility-driven synthetic contact matrices as a scalable solution for real-time pandemic response modeling.

Nature communications·2026

Related Experiment Video

Updated: May 10, 2026

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
11:15

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

Antibiotic reduction campaigns do not necessarily decrease bacterial resistance: the example of methicillin-resistant

Lidia Kardas-Sloma1, Pierre-Yves Boëlle, Lulla Opatowski

  • 1Laboratoire Modélisation et Surveillance des Risques pour la Sécurité Sanitaire, Conservatoire National des Arts et Métiers, Paris, France.

Antimicrobial Agents and Chemotherapy
|July 3, 2013
PubMed
Summary

Reducing antibiotic use globally requires careful planning. Class-specific changes, not just overall reductions, significantly impact antibiotic resistance, like methicillin-resistant Staphylococcus aureus (MRSA), necessitating coordinated hospital and community strategies.

More Related Videos

Preparation of Zinc Oxide Nanoparticles and the Evaluation of their Antibacterial Effects
06:42

Preparation of Zinc Oxide Nanoparticles and the Evaluation of their Antibacterial Effects

Published on: September 27, 2024

Related Experiment Videos

Last Updated: May 10, 2026

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
11:15

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

Preparation of Zinc Oxide Nanoparticles and the Evaluation of their Antibacterial Effects
06:42

Preparation of Zinc Oxide Nanoparticles and the Evaluation of their Antibacterial Effects

Published on: September 27, 2024

Area of Science:

  • Infectious Diseases
  • Mathematical Modeling
  • Public Health

Background:

  • Global efforts aim to reduce antibiotic consumption to combat antimicrobial resistance.
  • Current data limitations hinder accurate assessment of antibiotic reduction impacts on resistance selection.
  • Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant healthcare challenge.

Purpose of the Study:

  • To assess the impact of antibiotic class-specific reductions on MRSA selection.
  • To investigate interactions between hospital and community antibiotic prescription changes.
  • To model the transmission dynamics of methicillin-sensitive and methicillin-resistant Staphylococcus aureus (MSSA and MRSA).

Main Methods:

  • Development of a mathematical model for MSSA and MRSA transmission.
  • Systematic simulation study analyzing antibiotic class-specific changes.
  • Validation of the model using French ICU data and antibiotic consumption from 2002-2003.

Main Results:

  • Overall antibiotic reduction impacts on MRSA frequency varied widely (–69% to +52% in ICUs, –37% to +46% in the community).
  • The specific antibiotic classes reduced most critically influenced MRSA frequency.
  • Interactions between hospital and community antibiotic prescription changes showed synergistic or antagonistic effects on MRSA selection.

Conclusions:

  • Antibiotic reduction campaigns must consider class-specific changes, not just overall reductions, to predict impacts on MRSA.
  • Coordinated interventions in both hospital and community settings are crucial for optimizing gains against antibiotic resistance.
  • Exogenous factors significantly influence the effectiveness of interventions in specific settings.